Century Therapeutics, Inc.
Century Therapeutics, Inc. (IPSC) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
IPSC · net income · updated Jun 9, 2026
Core profitability metrics
IPSC · net income · margin · TTM · CAGRNet income was −$9.6M for FY2025 (fiscal year ending 2025-12-31), up 92.4% year-over-year. Net profit margin was -8.8%.
Annual net income history
▸ FMP /income-statement · Annual · IPSC net income history · IPSC profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Century Therapeutics, Inc. (IPSC) reported net income of −$9.6M for FY2025 (fiscal year ending 2025-12-31), up 92.4% year-over-year. The net profit margin was -8.8% — meaning the company kept $-0.09 of every dollar of revenue as profit.
Century Therapeutics, Inc. has not yet achieved annual profitability based on available data (7 fiscal years). The company has reported net losses across all available periods.
Century Therapeutics, Inc.'s net profit margin was -8.8% for FY2025, based on the latest annual results.
Investors sometimes search for "Century Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from IPSC net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
IPSC net income · 4 questionsCentury Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $9.6M for FY2025.
▸ Source: FMP /income-statement · GAAP · Century Therapeutics, Inc. · Century Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026